S96
An anti-SARS-CoV-2 monoclonal antibody.
General information
S96 is a monoclonal antibody that neutralizes the SARS-CoV-2 virus in vitro. It is a human IgG4 antibody targeting the RBD spike protein on the surface of the virus. This may prevent the spike protein from interacting with the ACE2 receptor on human cells, thereby blocking the virus from infecting the cells (Passariello et al., 2021).
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-3
Spike protein Novel compound Protein factor In vitro Mechanism Antibody |
Vero E6 cells | Substance S96 has a low neutralizing effect against SARS-CoV-2 infection. |
May/26/2021 |
